← Open Payments lookup

SHEILA CAI: Open Payments

NPI 1780625012 · SAN MARCOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,181 in 76 payments from 12 companies in 2025. Trend: 2023 $960 · 2024 $1,919 · 2025 $2,181

Food & beverage: $2,069Education: $111
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$531
Otsuka America Pharmaceutical, Inc.12$388
Supernus Pharmaceuticals, Inc.8$227
Vanda Pharmaceuticals Inc.7$196
Lundbeck LLC9$167
Teva Pharmaceuticals USA, Inc.5$153
E.R. Squibb & Sons, L.L.C.3$143
Corcept Therapeutics1$104
Alkermes, Inc.5$104
Neurocrine BioSciences, Inc.4$93

Products named: CAPLYTA, ABILIFY MAINTENA, Qelbree, REXULTI, HETLIOZ, COBENFY, ABILIFY ASIMTUFII, Korlym.

Industry payments across CA — which companies pay providers there.